ID: ALA3605114

Max Phase: Preclinical

Molecular Formula: C26H41NO3

Molecular Weight: 415.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@@H]1NC[C@]2(CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@]3(C)C(=O)CC[C@@H]43)C2)OC1=O

Standard InChI:  InChI=1S/C26H41NO3/c1-16(2)13-21-23(29)30-26(15-27-21)12-11-24(3)17(14-26)5-6-18-19-7-8-22(28)25(19,4)10-9-20(18)24/h16-21,27H,5-15H2,1-4H3/t17-,18-,19-,20-,21-,24-,25-,26+/m0/s1

Standard InChI Key:  ITRKRMVRBCMBFT-NDUUGVRDSA-N

Associated Targets(Human)

LAPC4 305 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Testosterone 17-beta-dehydrogenase 3 232 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 415.62Molecular Weight (Monoisotopic): 415.3086AlogP: 4.90#Rotatable Bonds: 2
Polar Surface Area: 55.40Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.89CX LogP: 5.29CX LogD: 5.28
Aromatic Rings: 0Heavy Atoms: 30QED Weighted: 0.65Np Likeness Score: 2.04

References

1. Djigoué GB, Kenmogne LC, Roy J, Maltais R, Poirier D..  (2015)  Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.,  23  (17): [PMID:26277760] [10.1016/j.bmc.2015.07.049]

Source